Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis.

Previous studies have shown that xanthine oxidase inhibitors (XOI) might improve outcome for patients with cardiovascular disease. However, more evidence is required.